AUPH Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Aurinia Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 15.35 USD 0.72% Market Closed

Market Cap: $2B

	Aurinia Pharmaceuticals Inc NASDAQ:AUPH	CA
	TYMLEZ Group Ltd ASX:TYM	AU
	Sovereign Metals Ltd ASX:SVM	AU
T	Telenor ASA DUS:TEQ	NO
	PG&E Corp NYSE:PCG	US
D	Domain Holdings Australia Ltd F:3DH	AU
M	MorphoSys AG XBER:MOR	DE
A	Aptiv PLC F:D7A	IE
	Phenom Resources Corp XTSX:PHNM	CA
	Moncler SpA MIL:MONC	IT
A	Alpha IVF Group Bhd KLSE:ALPHA	MY
A	Aurinia Pharmaceuticals Inc F:IKAP	CA

Profitability Summary

Aurinia Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

90%

Strong 3Y Average Gross Margin

90%

Declining Gross Margin

96% > 90%

Exceptional Operating Margin

42%

Negative 3Y Average Operating Margin

-6%

Operating Margin is Increasing

-52% > 42%

Exceptional Net Margin

100%

Low 3Y Average Net Margin

Net Margin is Increasing

-45% > 100%

Exceptional Free Cash Flow Margin

56%

Strong 3Y Average Free Cash Flow Margin

13%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.